Trinity Biotech is recognised as one of the primary sources for HbA1c analysis and detection of variant haemoglobins, which represent an important step in diabetes management. With its expertise in this field, the company provides high quality solutions for laboratories and healthcare providers worldwide.
With diabetes an increasing problem worldwide, HbA1c testing plays a critical role in diagnosing, monitoring and determining the treatment of high-risk patients. Trinity Biotech's solutions help to more precisely assess the health status of patients, while providing healthcare professionals with reliable and accurate results. This is vital for diabetes management and control.
Trinity Biotech is a benchmark in the industry with years of experience, superior technology and quality standards. Its solutions include medical equipment and test kits that can be used in both laboratory and point-of-care environments. In this way, healthcare professionals can rely on accurate and reliable results when monitoring patients' health status.
